Advanced Search
Your search returned 63 results
  • Jul 17, 2017
    The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder

    DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which provides sacral neuromodulation therapy, offers sustained long-term efficacy and quality of...

  • Mar 30, 2016
    New Medtronic Treatment Targets Underlying Bladder and Brain Miscommunication and Could Bring Desperately Needed Relief to Tens of Millions Struggling with OAB

    DUBLIN - March 30, 2016 - Medtronic plc (NYSE: MDT) today announced the launch of its NURO(TM) System that delivers percutaneous tibial neuromodulation (PTNM) for the treatment of overactive...

  • Nov 18, 2014
    Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported

    MINNEAPOLIS - Nov. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2015, which ended October 24, 2014. The company reported worldwide...

  • Oct 7, 2014
    FDA-Approved System Provides Patients with Added Benefits While Testing Innovative Therapy for Bladder and Bowel Incontinence

    MINNEAPOLIS - October 7, 2014 - After living with overactive bladder and urinary retention symptoms for 11 years, Jennifer LaForest, a 26-year-old woman from Auburn Hills, Michigan, recently...

  • Aug 19, 2014
    Revenue of $4.3 Billion Grew 4% on Constant Currency Basis; 5% as Reported

    MINNEAPOLIS - Aug. 19, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2015, which ended July 25, 2014. The company reported worldwide...

  • Aug 20, 2013
    Revenue of $4.1 Billion Grew 3% at Constant Currency; 2% as Reported

    MINNEAPOLIS - August 20, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2014, which ended July 26, 2013. The company reported worldwide...

  • May 21, 2013
    Q4 Revenue of $4.5 Billion Grew 5% at Constant Currency; 4% as Reported

    MINNEAPOLIS - May 21, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2013, which ended April 26, 2013. The Company reported worldwide...

  • Feb 19, 2013
    Revenue of $4.0 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

    MINNEAPOLIS - February 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2013, which ended January 25, 2013. The Company reported...

  • Nov 20, 2012
    Revenue of $4.1 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - November 20, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2013, which ended October 26, 2012. The Company reported...

  • Aug 21, 2012
    Revenue of $4.0 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - August 21, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2013, which ended July 27, 2012. The Company reported worldwide...

Show 5102550100 per page